Ausgabe 4/2011
Including PIH Articles on Understanding the Pathogenesis and the Evolving Treatment Paradigm for Multiple Myeloma in the Era of Novel Agents
Inhalt (17 Artikel)
Guest editorial: understanding the pathogenesis and the evolving treatment paradigm for multiple myeloma in the era of novel agents
Masahiro Abe
Update on risk stratification and treatment of newly diagnosed multiple myeloma
Prashant Kapoor, S. Vincent Rajkumar
The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma
Sarah K. Johnson, Christoph J. Heuck, Anthony P. Albino, Pingping Qu, Qing Zhang, Bart Barlogie, John D. Shaughnessy Jr.
Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma
Masahiro Abe
Novel therapies in MM: from the aspect of preclinical studies
Teru Hideshima, Kenneth C. Anderson
Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement
Kakunoshin Yoshida, Hideo Wada, Masahiro Hasegawa, Hiroki Wakabayashi, Honami Ando, Seika Oshima, Takeshi Matsumoto, Yuji Shimokariya, Katsura Noma, Norikazu Yamada, Atsumasa Uchida, Tsutomu Nobori, Akihiro Sudo
Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy
Dongho Kim, Hyun-Gyung Goh, Soo-Hyun Kim, Byung-Sik Cho, Dong-Wook Kim
An evaluation of peripherally inserted central venous catheters for children with cancer requiring long-term venous access
Naoki Hatakeyama, Tsukasa Hori, Masaki Yamamoto, Nobuo Mizue, Natsuko Inazawa, Keita Igarashi, Hiroyuki Tsutsumi, Nobuhiro Suzuki
Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia
Kazutaka Takagi, Yasukazu Kawai, Takahiro Yamauchi, Hiromichi Iwasaki, Takanori Ueda
Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: The Nagasaki Transplant Group experience
Takuya Fukushima, Jun Taguchi, Yukiyoshi Moriuchi, Shinichiro Yoshida, Hidehiro Itonaga, Koji Ando, Yasushi Sawayama, Yoshitaka Imaizumi, Daisuke Imanishi, Tomoko Hata, Yasushi Miyazaki
A new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute promyelocytic leukemia
Jun Yamanouchi, Takaaki Hato, Toshiyuki Niiya, Kazuhiro Miyoshi, Taichi Azuma, Ikuya Sakai, Masaki Yasukawa
Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia
Yoshikazu Nishi, Kazuko Hamamoto, Naoto Fujita, Satoshi Okada
Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
Kyoko Taniguchi, Masaya Okada, Satoshi Yoshihara, Akihiro Sawada, Tazuko Tokugawa, Shinichi Ishii, Katsuji Kaida, Kazuhiro Ikegame, Kentaro Minagawa, Toshimitsu Matsui, Hiroyasu Ogawa
Dissociation of ferritin and hepcidin in a case of adult-onset Still’s disease
Hannah Tharmalingam, Damien R. Ashby, Mark Busbridge, Candice Roufosse, Tom D. Cairns
Type 2B-like acquired von Willebrand syndrome
Toshio Shigekiyo, Etsuko Sekimoto, Atsuhisa Shirakami, Hiroshi Yamaguchi, Hironobu Shibata, Shuji Ozaki, Kazuya Kanda, Seiya Saito, Nobuo Satake, Osamu Fujino
Report of the Fifth Meeting of the International Network for Pediatric Hemophilia: a focus on prophylaxis and immune tolerance induction
Rolf Ljung, Johannes Oldenburg, Günter Auerswald, Marijke van den Berg, Midori Shima, Donna DiMichele